secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADMA BIOLOGICS, INC. (ADMA)
CIK:        0001368514
Form:       8-K
Filed at:   2024-10-09T23:59:59+00:00
Accession:  0001140361-24-043222
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADMA Biologics auditor CohnReznick resigning effective after Q3 2024 filing; audit committee seeking replacement
--------------------------------------------------------------------------------

- CohnReznick LLP notified ADMA of resignation as independent auditor effective after filing of Q3 2024 10-Q.
- No disagreements or reportable events during fiscal years 2022 and 2023 or subsequent interim period.
- Audit Committee initiated process to select new auditor for FY 2024 audit and internal control over financial reporting.
- CohnReznick's reports on FY 2023 and 2022 financials were unqualified, no adverse opinion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124043222/0001140361-24-043222-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124043222/ef20037071_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-043222

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer